Sponsor Pipeline

Lumos Pharma Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
6
Active Trials
1
Recruiting
2
Phase 3
1
Disease Areas
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-08-10 NCT07754045 Evaluating the Efficacy and Safety of LUM-201 Plus Semaglutide Versus Semaglutide Plus… Phase 2 Not Yet Recruiting
2026-07-28 NCT07732413 Trial of NLG802 Indoximod Prodrug Plus Temozolomide for Patients With Progressive… Phase 1 Not Yet Recruiting
Active Trials by Phase
Phase 3
2
Phase 2
3
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06948214 Phase 3 Study of LUM-201 in Children With Growth Hormone Deficiency Growth Hormone Deficiency (GHD) Recruiting
NCT07129759 Phase 3 Long Term Safety Extension Study of LUM-201 in Children With Growth Hormone… Growth Hormone Deficiency (GHD) Not Yet Recruiting
Phase 2
NCT04806854 PK and PD Study of LUM-201 in Children With Idiopathic Growth Hormone Deficiency… Growth Hormone Deficiency Active, Not Recruiting
NCT05796440 A Long-Term Safety Trial of LUM-201 in Children With Idiopathic Growth Hormone Deficiency… Growth Hormone Deficiency Enrolling by Invitation
NCT07754045 Evaluating the Efficacy and Safety of LUM-201 Plus Semaglutide Versus Semaglutide Plus… Obesity & Overweight Not Yet Recruiting
Phase 1
NCT07732413 Trial of NLG802 Indoximod Prodrug Plus Temozolomide for Patients With Progressive… Progressive Pediatric Brain Cancer Not Yet Recruiting
Disease Areas
Get alerts when Lumos Pharma's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free